In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
As of close of business last night, Capricor Therapeutics Inc’s stock clocked out at $9.29, up 4.62% from its previous closing price of $8.88. In other words, the price has increased by $4.62 from its previous closing price. On the day, 0.73 million shares were traded. CAPR stock price reached its highest trading level at $9.4 during the session, while it also had its lowest trading level at $8.7201.
Ratios:
To gain a deeper understanding of CAPR’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 7.77 and its Current Ratio is at 7.77. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.03.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Piper Sandler on October 21, 2024, initiated with a Overweight rating and assigned the stock a target price of $35.
On May 17, 2024, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $14.
On January 05, 2024, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $8.Cantor Fitzgerald initiated its Overweight rating on January 05, 2024, with a $8 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Sep 20 ’24 when Nippon Shinyaku Co Ltd bought 2,798,507 shares for $5.36 per share. The transaction valued at 14,999,998 led to the insider holds 7,090,351 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CAPR now has a Market Capitalization of 424338400 and an Enterprise Value of 274267168. For the stock, the TTM Price-to-Sale (P/S) ratio is 19.06 while its Price-to-Book (P/B) ratio in mrq is 2.91. Its current Enterprise Value per Revenue stands at 12.315 whereas that against EBITDA is -6.667.
Stock Price History:
The Beta on a monthly basis for CAPR is 0.94, which has changed by 0.5853243 over the last 52 weeks, in comparison to a change of 0.059571505 over the same period for the S&P500. Over the past 52 weeks, CAPR has reached a high of $23.40, while it has fallen to a 52-week low of $3.52. The 50-Day Moving Average of the stock is -28.18%, while the 200-Day Moving Average is calculated to be -21.53%.
Shares Statistics:
It appears that CAPR traded 1.27M shares on average per day over the past three months and 1645150 shares per day over the past ten days. A total of 45.58M shares are outstanding, with a floating share count of 40.12M. Insiders hold about 12.16% of the company’s shares, while institutions hold 38.86% stake in the company. Shares short for CAPR as of 1743379200 were 9303425 with a Short Ratio of 7.34, compared to 1740700800 on 8166040. Therefore, it implies a Short% of Shares Outstanding of 9303425 and a Short% of Float of 23.169999999999998.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
